Clinical Trial Update: Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating anticoagulation in patients with COVID-19 pneumonia within the Corimmuno-19 cohort; status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: COVID19 Pneumonia | Phase 2 | Status: UNKNOWN